At Future Mobility, our mission is clear: to enable people to work safer, for longer, and with greater confidence by implementing innovative wearable technology that supports individuals through their daily tasks, improving quality of life both inside and outside of work. 

We are a UK-based specialist integrator of occupational exoskeletons, partnering with leading international manufacturers to deliver clinically relevant, ergonomically designed solutions to frontline services. Our objective is simple — to reduce preventable injury, protect valuable staff, and help organisations build more resilient and reliable workforces. 

Our portfolio includes both passive and active powered exoskeletons that support the back, shoulders and upper limbs during physically demanding tasks. These lightweight, non-invasive wearable devices integrate seamlessly into existing workflows. In healthcare environments, they assist during patient handling, repetitive clinical procedures, prolonged static postures, equipment movement and facilities operations. Our solutions span both preventative occupational use and rehabilitative support, allowing flexible deployment aligned with operational needs. 

Future Mobility was founded in response to a clear and persistent challenge: musculoskeletal strain remains one of the most costly and widespread issues across UK workplaces, particularly within healthcare. Long-term sickness absence and workforce attrition create substantial financial and human impact. Large-scale automation and robotics are often cost-prohibitive or impractical in clinical settings, yet global innovation in wearable robotics has advanced rapidly. The opportunity was to bring proven exoskeleton technology into UK healthcare, where it can deliver measurable, real-world benefit. 

Across NHS Scotland, musculoskeletal disorders (MSDs) are among the leading causes of staff absence, alongside stress and mental health-related conditions. Sickness absence rates have remained around 6–7% in recent reporting periods, equating to millions of lost working hours each year. Manual handling injuries, repetitive strain and cumulative back and shoulder conditions are significant contributors. Even a one percentage point reduction in absence would represent meaningful cost savings, improved continuity of care and reduced strain on frontline teams. 

The challenge extends beyond absence statistics. NHS Scotland operates within constrained budgets, workforce shortages and rising patient demand. Protecting experienced nurses, healthcare assistants, porters, estates teams and clinicians is not solely a health and safety objective — it is fundamental to long-term service sustainability. Reducing preventable injury directly supports retention, morale and operational resilience. 

Our exoskeleton solutions address these issues by mitigating biomechanical risk at source. By reducing spinal loading during patient transfers, decreasing shoulder fatigue during repetitive tasks and supporting posture during prolonged standing, they reduce cumulative strain before injury occurs. Unlike reactive measures, exoskeletons function as preventative equipment — effectively a new category of personal protective equipment focused on musculoskeletal risk reduction. 

International adoption in healthcare and industry has demonstrated reductions in perceived exertion, muscle activation and fatigue. When deployed alongside established moving and handling protocols, exoskeletons enhance — not replace — existing safety practices. 

At Future Mobility, we work collaboratively with organisations to pilot, evaluate and implement solutions responsibly. Our structured approach includes ergonomic assessment, staff engagement, training and performance monitoring to ensure alignment with clinical governance, procurement frameworks and operational priorities. 

We also provide flexible commercial models, including Mobility as a Service (MaaS) — a scalable, CAPEX-free alternative to outright purchase. Contracts range from 12 to 60 months and include training, maintenance, upgrades and ongoing support within a single transparent monthly fee. This approach removes capital barriers, ensures cost clarity and enables organisations to adopt evolving technology without ownership complexity. 

For NHS Scotland, the opportunity is clear: protect the workforce, reduce MSK-related absence, improve staff wellbeing and strengthen frontline resilience. Wearable assistive technology is no longer aspirational — it is a practical, deployable solution available today to safeguard the people who safeguard our health.